This page shows the publications co-authored by Galit Alter and Eric Nilles.
Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2. J Appl Lab Med. 2021 Jul 01.
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19. bioRxiv. 2021 May 12.
Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun. 2021 02 15; 12(1):1018.
Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021 03; 27(3):454-462.
Epidemiological and immunological features of obesity and SARS-CoV-2. medRxiv. 2020 Dec 11.
SARS-CoV-2-specific ELISA development. J Immunol Methods. 2020 Sep - Oct; 484-485:112832.
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2. medRxiv. 2020 Jun 26.
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma. medRxiv. 2020 Sep 03.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.